Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Solli · SciRah

Researcher profile · Semantic Scholar

V. Solli

Share profile

V. Solli — researcher profile on SciRah

h-index: 8
Works: 80
Citations: 258

Most-cited papers

Chromothripsis in acute myeloid leukemia: biological features and impact on survival
M. Fontana, G. Marconi, J. D. Milosevic Feenstra, Eugenio Fonzi +23 more
2017Leukemia103 citations Open access
Semantic Scholar
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma
M. Martello, A. Poletti, E. Borsi, V. Solli +15 more
2022Blood Cancer Journal37 citations Open access
Semantic Scholar
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis
M. Martello, V. Solli, G. Mazzocchetti, A. Solimando +19 more
2024Blood Cancer Journal22 citations Open access
Semantic Scholar
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features
C. Terragna, A. Poletti, V. Solli, M. Martello +16 more
2024Nature Communications12 citations Open access
Semantic Scholar
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients
E. Borsi, I. Vigliotta, A. Poletti, G. Mazzocchetti +18 more
2024Cells11 citations Open access
Semantic Scholar
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents
C. Papayannidis, J. Nanni, G. Cristiano, G. Marconi +16 more
2022European Journal of Haematology11 citations Open access
Semantic Scholar
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
K. Mancuso, E. Zamagni, V. Solli, L. Gabrielli +22 more
2023Frontiers in Oncology9 citations Open access
Semantic Scholar
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients
I. Vigliotta, V. Solli, S. Armuzzi, M. Martello +16 more
2024Cancers8 citations Open access
Semantic Scholar
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
I. Vigliotta, S. Armuzzi, Martina Barone, V. Solli +18 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma
A. Poletti, B. Taurisano, G. Mazzocchetti, M. Lionetti +20 more
2025Haematologica6 citations Open access
Semantic Scholar
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients
E. Borsi, G. Mazzocchetti, A. F. Dico, I. Vigliotta +15 more
2023Clinical and Experimental Medicine (Testo stampato)5 citations Open access
Semantic Scholar
Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study
K. Mancuso, R. Mina, S. Rocchi, E. Antonioli +21 more
2024Cancer Medicine4 citations Open access
Semantic Scholar
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles
G. Mazzocchetti, A. Poletti, V. Solli, E. Borsi +7 more
2022Computational and Structural Biotechnology Journal4 citations Open access
Semantic Scholar
OA-14 Prospective Functional Bone Disease Evaluation of Newly Diagnosed Multiple Myeloma with Combined Use of (18)F-FDG-PET/CT and Whole-Body Diffusion Weighted Magnetic Resonance
M. Talarico, Gabriella De Cicco, P. Tacchetti, L. Pantani +19 more
2024Clinical Lymphoma, Myeloma & Leukemia3 citations
Semantic Scholar
Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome
F. Pirini, G. Tedaldi, R. Danesi, Ilaria Cangini +14 more
2019International Journal of Colorectal Disease3 citations
Semantic Scholar
Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real‐World Evidence in a Rapidly Evolving Therapeutic Landscape
K. Mancuso, S. Masci, M. Talarico, A. Vitale +15 more
2026European Journal of Haematology2 citations Open access
Semantic Scholar
P-416 A Multicenter Observational Retrospective Study of Second-Line Treatment With Daratumumab–Bortezomib–Dexamethasone (DaraVd) in Multiple Myeloma (MM) Patients Refractory to Lenalidomide
I. Rizzello, I. Sacchetti, S. Barbato, V. Solli +20 more
2024Clinical Lymphoma, Myeloma & Leukemia2 citations
Semantic Scholar
Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma
F. Bigi, P. Tacchetti, Alessandro Giorgi, G. Mazzocchetti +13 more
2024Frontiers in Hematology2 citations Open access
Semantic Scholar
A multicenter observational retrospective study of second-line treatment with daratumumab–bortezomib–dexamethasone (DaraVd) in multiple myeloma patients refractory to lenalidomide
I. Rizzello, I. Sacchetti, S. Barbato, V. Solli +22 more
2025Clinical and Experimental Medicine (Testo stampato)1 citations Open access
Semantic Scholar
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
M. Martello, V. Solli, R. Termini, A. Kanapari +16 more
2022International Journal of Molecular Sciences1 citations Open access
Semantic Scholar
OAB-059: Towards a comprehensive multimodal minimal residual disease assessment in multiple myeloma: the role of circulating cell-free DNA to define the extent of disease spreading
M. Martello, A. Poletti, E. Borsi, B. Taurisano +13 more
2021Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
High Humoral Response after Anti-Sars-Cov-2 mRNA-Based Vaccines in Patients with Active Multiple Myeloma (MM) and Relationship with Disease Status/Line of Therapy
K. Mancuso, E. Zamagni, V. Solli, L. Gabrielli +15 more
2021Blood1 citations Open access
Semantic Scholar
Negative Selective Pressure Exerted By Maintenance Therapy Promotes the Extinction of Sub-Clones Carrying High-Risk Lesions in Multiple Myeloma
C. Terragna, A. Poletti, V. Solli, M. Martello +19 more
2019Blood1 citations Open access
Semantic Scholar
Chromothripsis in Acute Myeloid Leukemia: biological features and impact on survival
M. Fontana, G. Marconi, J. D. M. Feenstra, E. Fonzi +23 more
2017Leukemia1 citations Open access
Semantic Scholar
A Branching Evolution Model at Relapse Characterizes Multiple Myeloma Patients Who Responded to up-Front Combination Therapy Including New Drugs
C. Terragna, M. Martello, Barbara Santacroce, V. Solli +13 more
20161 citations
Semantic Scholar
B07 | PROGNOSTIC ROLE OF STANDARDIZED (18)F-FDG-PET/CT AND WB-DW-MRI IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS RECEIVING T CELL-REDIRECTING THERAPIES
M. Talarico, A. Cattabriga, L. Pagnini, V. Solli +18 more
2026Haematologica0 citations Open access
Semantic Scholar
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real‐Life Italian Multicenter Harmonization Experience
Stefania Oliva, M. Martello, E. Saraci, S. Armuzzi +34 more
2026Cancer Medicine0 citations Open access
Semantic Scholar
PA-026 An Integrated High-Sensitivity Flow Cytometry Platform Revealing Dissemination-Associated Phenotypes and Therapeutic Target Heterogeneity in Multiple Myeloma: The MMulticolors Panel
A. Varacalli, I. Vigliotta, A. Laganà, B. Taurisano +14 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Circulating plasma cells (polyclonal and monoclonal) as markers of an aggressive multiple myeloma phenotype
I. Vigliotta, A. Varacalli, V. Solli, B. Taurisano +14 more
2026Scientific Reports0 citations Open access
Semantic Scholar
P16 | INTEGRATED p53 ISOFORM EXPRESSION DEFINES NOVEL PROGNOSTIC SUBGROUPS IN MULTIPLE MYELOMA
E. Borsi, A. Vitale, V. Solli, V. M. Vuong +14 more
2026Haematologica0 citations Open access
Semantic Scholar
PA-431 Safety and Feasibility of Outpatient Bispecific Antibodies Step-Up Doses Administration for the Treatment of Relapsed/Refractory Multiple Myeloma: A Real-World Multicenter Study
M. Puppi, E. Manzato, Paola Boggione, Federico Monaco +21 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
OA-36 Longitudinal Liquid Biopsy Monitoring Reveals Distinct Residual Disease Dynamics Beyond Bone Marrow MRD Assessment in Newly Diagnosed Multiple Myeloma
C. Terragna, V. Solli, I. Vigliotta, M. Martello +21 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
LBA-26 High-Sensitivity Longitudinal Circulating Plasma Cells Monitoring After T-Cell-Redirecting Therapies: The Impact of Early Clearance on Response and Survival Outcomes
I. Vigliotta, A. Varacalli, M. Talarico, E. Manzato +11 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework
S. Peluso, Stefano Polizzi, L. Pagnini, M. Tarozzi +11 more
2026European Journal of Nuclear Medicine and Molecular Imaging0 citations Open access
Semantic Scholar
PA-051 Beyond Consensus Genomic Staging: Genomic Heterogeneity of Relapsed Standard-Risk Multiple Myeloma
V. M. Vuong, V. Solli, B. Taurisano, I. Vigliotta +18 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
P46 | CIRCULATING PLASMA CELLS AS A DYNAMIC BIOMARKER IN MULTIPLE MYELOMA PATIENTS RECEIVING CAR-T AND BISPECIFIC ANTIBODY THERAPY
I. Vigliotta, A. Varacalli, M. Talarico, M. Puppi +15 more
2026Haematologica0 citations Open access
Semantic Scholar
Paraskeletal disease in multiple myeloma after treatment: is there a possible prognostic role of whole-body low dose CT (WBLDCT) vs. 18 F-FDG-PET/CT?
Davide Bezzi, E. Zamagni, M. Di Franco, M. Talarico +7 more
2026Clinical and translational imaging0 citations Open access
Semantic Scholar
PA-285 Longitudinal ctDNA Profiling Enables Early Detection of Relapse and Clonal Dynamics in Multiple Myeloma
M. Martello, G. Mazzocchetti, B. Taurisano, A. Poletti +17 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
P18 | MONOCLONAL AND POLYCLONAL CIRCULATING PLASMA CELLS ARE ASSOCIATED WITH DISEASE DISSEMINATION IN MULTIPLE MYELOMA
I. Vigliotta, A. Varacalli, M. Talarico, V. Solli +16 more
2026Haematologica0 citations Open access
Semantic Scholar
PA-500 TP53 Isoform Switching Defines Functional States and Clinical Risk in Multiple Myeloma
E. Borsi, A. Vitale, V. Solli, V. M. Vuong +11 more
2026Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma
M. Talarico, G. Vischini, S. Barbato, R. Restuccia +17 more
2025Frontiers in Oncology0 citations Open access
Semantic Scholar
Prospective Evaluation of Response Assessment in Newly-Diagnosed Multiple Myeloma with Combined use of 18F-FDG-PET/CT, Whole-Body Diffusion-Weighted MRI and MRD by Next-Generation Sequencing
M. Talarico, A. Cattabriga, M. Di Franco, V. Solli +19 more
2025Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapy
G. Gargano, S. A. Pappagallo, A. Quinto, B. Rossini +13 more
2025Scientific Reports0 citations Open access
Semantic Scholar
Comparative Analysis of Four NGS Protocols for Measurable Residual Disease Assessment Testing ctDNA and Bone Marrow Samples in Multiple Myeloma
S. Armuzzi, A. Schilhabel, B. Taurisano, M. Martello +11 more
2025Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Charting Spatial Heterogeneity in Multiple Myeloma by Using a Minimally Invasive Cell-free DNA Profiling
M. Martello, G. Mazzocchetti, B. Taurisano, V. Solli +20 more
2025Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction
Carmen Baldazzi, L. Bandini, V. Robustelli, A. Patuelli +12 more
2025International Journal of Molecular Sciences0 citations Open access
Semantic Scholar
Real-World Evidence of Melflufen Plus Dexamethasone in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients: Efficacy and Safety from a Single-Center Experience
K. Mancuso, S. Masci, M. Talarico, A. Vitale +14 more
2025Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Monoclonal and polyclonal circulating plasma cells (CPCs) are linked to disease spread in multiple myeloma
I. Vigliotta, A. Varacalli, M. Talarico, V. Solli +17 more
2025Blood0 citations
Semantic Scholar
P-383 A 16-gene signature reflecting tumor microenvironment predicts the risk of multiple myeloma patients treated by bortezomib-based therapies
G. Gargano, S. A. Pappagallo, A. Quinto, B. Rossini +12 more
2023Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
OA-22 TiMMing: developing an innovative suite of bioinformatic tools to harmonize and track the origin of copy number alterations in the evolutionary history of multiple myeloma
A. Poletti, Jean-Baptiste Alberge, G. Mazzocchetti, V. Solli +16 more
2023Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Terragna×36
Invite
C. Terragna — researcher profile on SciRah
E. Zamagni×32
Invite
E. Zamagni — researcher profile on SciRah
P. Tacchetti×31
Invite
P. Tacchetti — researcher profile on SciRah
S. Armuzzi×28
Invite
S. Armuzzi — researcher profile on SciRah

×27

Invite

L. Pantani — researcher profile on SciRah

Invite

K. Mancuso — researcher profile on SciRah

M. Martello×26

Invite

M. Martello — researcher profile on SciRah

Invite

E. Borsi — researcher profile on SciRah

I. Vigliotta×26

Invite

I. Vigliotta — researcher profile on SciRah

B. Taurisano×26

Invite

B. Taurisano — researcher profile on SciRah

I. Rizzello×25

Invite

I. Rizzello — researcher profile on SciRah

Invite

I. Pistis — researcher profile on SciRah